Want to buy for someone else? You can purchase a token at check out.

This course is free with a membership upgrade!

Upgrade to a Standard membership and gain access to 1,000+ CE and professional development courses.

Overview
Goals and Outcomes
Details
Accreditations
Overview
Overview
Obesity is at epidemic levels in the U.S. Over 40% of adults in the U.S. are obese (Centers for Disease Control and Prevention [CDC], 2022a). The disorder has created an enormous burden on the healthcare system and has untold social and personal ramifications. This course will focus on medications approved for long-term use for chronic weight management.

All drug-related information cited in this course was obtained from the manufacturer package inserts accessed January 31, 2023 unless otherwise noted.
Goals and Outcomes
Goals and Learning Outcomes
The goal of this course is to provide an overview of long-term pharmacological treatments for weight loss to those members of the healthcare team who may treat patients who have obesity.

After taking this course, you should be able to:
  • Identify nonpharmacological support measures needed by patients with obesity.
  • Recall the classes of drugs available for the management of obesity and their mechanism of action.
  • Recognize the warning signs, precautions, and adverse effects of drugs approved to treat obesity.
Details
Course Details

Course Originally Released on : 3/31/2023

REL-ACU-0-POWL

Accreditations
Accreditations

NURSES
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Provider approved by the California Board of Registered Nursing, CEP#13791

Accreditations imageAccreditations image

Disclaimer: Not all courses will provide California Board of Registered Nursing approval. Per California Assembly Bill No. 241, continuing education courses related to direct patient care shall address at least one or a combination of the following:(1) Examples of how implicit bias affects perceptions and treatment decisions of licensees, leading to disparities in health outcomes; or (2) Strategies to address how unintended biases in decision-making may contribute to health care disparities by shaping behavior and producing differences in medical treatment along lines of race, ethnicity, gender identity, sexual orientation, age, socioeconomic status, or other characteristics.

CEBroker
Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, New Mexico Board Of Nursing, South Carolina Board Of Nursing and West Virginia Board Of Examiners For Registered Professional Nurses
Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.

Disclosures
None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.